References
- SelkoeDJTranslating cell biology into therapeutic advances in Alzheimer’s diseaseNature1999399supplA23A3110392577
- XiaWAmyloid inhibitors and Alzheimer’s diseaseCurr Opin Investig Drugs2003415559
- XiaWAmyloid metabolism and secretases in Alzheimer’s diseaseCurr Neurol Neurosci Rep2001142242711898552
- HymanBTTanziREMarzloffKBarbourRSchenkDKunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer’s diseaseJ Neuropathol Exp Neurol199251176831740675
- EdbauerDWinklerERegulaJTPesoldBSteinerHHaassCReconstitution of gamma-secretase activityNat Cell Biol2003548648812679784
- WolfeMSXiaWOstaszewskiBLDiehlTSKimberlyWTSelkoeDJTwo transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activityNature199939851351710206644
- YuGNishimuraMArawakaSNicastrin modulates presenilinmediated notch/glp-1 signal transduction and betaAPP processingNature20004076800485410993067
- ChenFYuGArawakaSNicastrin binds to membrane-tethered NotchNat Cell Biol2001375175411483961
- GoutteCTsunozakiMHaleVAPriessJRAPH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryosProc Natl Acad Sci200299277577911792846
- FrancisRMcGrathGZhangJaph-1 and pen-2 are required for Notch pathway signaling, g-secretase cleavage of bAPP and presenilin protein accumulationDev Cell20023859712110170
- SelkoeDJSoluble oligomers of the amyloid beta-protein impair synaptic plasticity and behaviorBehav Brain Res2008192110611318359102
- XiaWYangTShankarGA Specific ELISA for Measuring Amyloid β-Protein Oligomer in Human Plasma and the Brains of Alzheimer PatientsArch Neurol2008662110
- LueLFKuoYMRoherAESoluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s diseaseAm J Pathol1999155385386210487842
- McLeanCAChernyRAFraserFWSoluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s diseaseAnn Neurol199946686086610589538
- NaslundJHaroutunianVMohsRCorrelation between elevated levels of amyloid beta-peptide in the brain and cognitive declineJAMA2000283121571157710735393
- ScheunerDEckmanCJensenMSecreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s diseaseNature Med1996288648708705854
- EnyaMMorishima-KawashimaMYoshimuraMAppearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during agingAm J Pathol199915412712799916941
- PodlisnyMBOstaszewskiBLSquazzoSLAggregation of secreted amyloid β-protein into SDS-stable oligomers in cell cultureJ Biol Chem1995270956495707721886
- XiaWZhangJKholodenkoDEnhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilinsJ Biol Chem199727212797779829065468
- GravinaSAHoLEckmanCBAmyloid beta protein (A beta) in Alzheimer’s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)J Biol Chem199527013701370167706234
- BitanGKirkitadzeMDLomakinAVollersSSBenedekGBTeplowDBAmyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathwaysProc Natl Acad Sci U S A2003100133033512506200
- KawarabayashiTShojiMYounkinLHDimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer’s diseaseJ Neurosci200424153801380915084661
- MuckeLMasliahEYuGQHigh-level neuronal expression of A beta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formationJ Neurosci200020114050405810818140
- HsiaAYMasliahEMcConlogueLPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse modelsProc Natl Acad Sci U S A19999663228323310077666
- O’HareEWeldonDTMantyhPWDelayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)Brain Res199981511109974116
- KimJHAnwylRSuhYHDjamgozMBRowanMJUse-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivoJ Neurosci20012141327133311160403
- LambertMPBarlowAKChromyBADiffusible, nonfribrillar ligands derived from Ab−42 are potent central nervous system neurotoxinsProc Natl Acad Sci U S A199895644864539600986
- GongYChangLViolaKLAlzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory lossProc Natl Acad Sci U S A2003100181041710422 Epub 12003 Aug 1041812925731
- WangHWPasternakJFKuoHSoluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrusBrain Res2002924213314011750898
- WalshDMFadeevaJVLaVoieMJgamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteinsBiochemistry200342226664667312779321
- TownsendMShankarGMMehtaTWalshDMSelkoeDJEffects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimersJ Physiol2006572Pt 247749216469784
- ShankarGMLiSMehtaTHAmyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memoryNat Med200814883784218568035
- ClearyJPWalshDMHofmeisterJJNatural oligomers of the amyloid-beta protein specifically disrupt cognitive functionNat Neurosci200581798415608634
- LesneSKohMTKotilinekLA specific amyloid-beta protein assembly in the brain impairs memoryNature2006440708235235716541076
- SnyderEMNongYAlmeidaCGRegulation of NMDA receptor trafficking by amyloid-betaNat Neurosci2005881051105816025111
- WangQRowanMJAnwylRBeta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxideJ Neurosci200424276049605615240796
- LacorPNBunielMCFurlowPWAbeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s diseaseJ Neurosci200727479680717251419
- MolnarZSoosKLengyelIPenkeBSzegediVBudaiDEnhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivoNeuroreport200415101649165215232300
- ShankarGMBloodgoodBLTownsendMWalshDMSelkoeDJSabatiniBLNatural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathwayJ Neurosci200727112866287517360908
- HarkanyTAbrahamITimmermanWbeta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalisEur J Neurosci20001282735274510971616
- RaymondCRIrelandDRAbrahamWCNMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampusBrain Res2003968226327212663096
- HsiehHBoehmJSatoCAMPAR removal underlies Abetainduced synaptic depression and dendritic spine lossNeuron200652583184317145504
- ChangEHSavageMJFloodDGAMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin miceProc Natl Acad Sci U S A200610393410341516492745
- OrigliaNRighiMCapsoniSReceptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunctionJ Neurosci200828133521353018367618
- OsakaHMukherjeePAisenPPasinettiGComplement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicityJ Cell Biochem199873330331110321830
- OsakaHMcGintyAHöepkenULuBGerardCPasinettiGExpression of C5a receptor in mouse brain: role in signal transduction and neurodegenerationNeuroscience1999881073108210336122
- MukherjeePPasinettiGMThe role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer’s diseaseJ Neuroimmunol2000105212413010742554
- LaurenJGimbelDANygaardHBGilbertJWStrittmatterSMCellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomersNature200945772331128113219242475
- BalducciCBeegMStravalaciMSynthetic amyloid-beta oligomers impair long-term memory independently of cellular prion proteinProc Natl Acad Sci U S A201010752295230020133875
- GuQBZhaoJXFeiJSchwarzWModulation of Na(+),K(+) pumping and neurotransmitter uptake by beta-amyloidNeuroscience20041261616715145073
- ChenQSWeiWZShimaharaTXieCWAlzheimer amyloid betapeptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrusNeurobiol Learn Mem200277335437111991763
- DemuroAMinaEKayedRMiltonSCParkerIGlabeCGCalcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomersJ Biol Chem200528017172941730015722360
- NassifMHoppeJSantinKBeta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3beta, and PTENNeurochem Int200750122923517018242
- DineleyKTWestermanMBuiDBellKAsheKHSweattJDBeta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer’s diseaseJ Neurosci200121124125413311404397
- TownsendMMehtaTSelkoeDJSoluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathwayJ Biol Chem200728246333053331217855343
- McLaurinJKiersteadMEBrownMECyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse modelNat Med200612780180816767098
- TownsendMClearyJPMehtaTOrally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomersAnn Neurol200660666867617192927
- WalshDMTownsendMPodlisnyMBCertain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiationJ Neurosci200525102455246215758153
- WalshDMKlyubinIShankarGMThe role of cell-derived oligomers of Abeta in Alzheimer’s disease and avenues for therapeutic interventionBiochem Soc Trans200533Pt 51087109016246051
- DodartJCBalesKRGannonKSImmunization reverses memory deficits without reducing brain Abeta burden in Alzheimer’s disease modelNat Neurosci20025545245711941374
- KlyubinIWalshDMLemereCAAmyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivoNat Med200511555656115834427
- KotilinekLABacskaiBWestermanMReversible memory loss in a mouse transgenic model of Alzheimer’s diseaseJ Neurosci200222156331633512151510
- SchenkDBarbourRDunnWImmunization with amyloid-?attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature199940017317710408445
- TownsendMQuYGrayAOral treatment with a gamma-secretase inhibitor improves long-term potentiation in a mouse model of Alzheimer’s DiseaseJ Pharmacol Exp Ther2010333111011920056779
- EriksenJLSagiSASmithTENSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoJ Clin Invest2003112344044912897211
- SiemersERQuinnJFKayeJEffects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseNeurology200666460260416505324
- SiemersERDeanRAFriedrichSSafety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretaseClin Neuropharmacol200730631732518090456
- FleisherASRamanRSiemersERPhase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer diseaseArch Neurol20086581031103818695053
- HenleyDBMayPCDeanRASiemersERDevelopment of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer’s diseaseExpert Opin Pharmacother200910101657166419527190
- MayerSCKreftAFHarrisonBDiscovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer’s diseaseJ Med Chem200851237348735119012391
- HardyJSelkoeDJThe amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeuticsScience2002297558035335612130773